Background illustration for clinical trials search

Paid Clinical Trials Orange County

Discover 3,622 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase 2, Recruiting

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

for
Primary Central Nervous System Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06922604

Phase 1, Recruiting

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

for
Atopic Dermatitis
Location: Los Angeles CA, Henderson NV, Las Vegas NV, Phoenix AZ,
Sponsor: Castle Biosciences Incorporated

Sex: All

Age: 12 - 70+

Code: NCT07645820

Recruiting

Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Duarte CA, Los Angeles CA, Santa Monica CA,
Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06295731

Phase 2, Phase 3, Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

for
Stroke, TIA, Ischemic Stroke, Ischemic
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 30+

Code: NCT05518305

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Polyphenols and Cognitive Decline

for
Cognitive Decline, Cognitive Dysfunction
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 50+

Code: NCT06507254

Recruiting

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

for
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06014827

Phase 2, Recruiting

Acoustic and Electrical Stimulation for the Treatment of Tinnitus

for
Tinnitus
Location: Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT03511807

Recruiting

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

for
Metastatic Malignant Neoplasm in the Bone,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06549478

Phase 1, Recruiting

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

for
Breast Carcinoma, Colorectal Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06130826

Phase 1, Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Torrance CA, Stockton CA, Salem OR, Tacoma WA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

for
Recurrent Astrocytoma, IDH-Mutant, Grade 3,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06815029

Phase 1, Recruiting

Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06498973

Phase 1, Recruiting

Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy

for
Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8
Location: Duarte CA, Columbus OH
Sponsor: City of Hope Medical Center

Sex: All

Age: 60+

Code: NCT06139627

Recruiting

A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

for
Acute Treatment of Migraine
Location: Los Angeles CA, Canoga Park CA, Las Vegas NV, Fresno CA,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07609914

Phase 4, Recruiting

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06054776

Phase 2, Recruiting

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

for
Non-small Cell Lung Cancer (NSCLC)
Location: Glendale CA, Los Angeles CA, San Francisco CA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566052

Phase 3, Recruiting

fNIRS for Disorders of Consciousness

for
Disorders of Consciousness Due to Severe Brain Injury,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18+

Code: NCT07485361

Recruiting

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

for
Cutaneous Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04670874

Recruiting

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

for
Advanced Prostate Carcinoma, Metastatic Prostate Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Male

Age: 60+

Code: NCT05869682

Phase 2, Recruiting